A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors

NCT06826313 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

BIOLOGICAL: VRT106

Sponsor

Guangzhou Virotech Pharmaceutical Co., Ltd.

Collaborators

[object Object]